FridaySep 15, 2023 12:11 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Optimistic Berubicin May Provide Much-Needed Benefit for GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company specializing in the development of novel treatments with a focus on brain cancer, glioblastoma (“GBM”) and neuro-oncology, recently presented updated safety results from its potentially pivotal clinical study on GBM treatment through its lead drug candidate, Berubicin. “Most notably, this novel anthracycline demonstrated its capability to be a safe and innovative potential treatment option for GBM, having shown aspects integral to effective therapy for the disease… So far, 151 patients have been enrolled in the clinical study, with 105 set on Berubicin while the remaining 46 will be on Lomustine. This marks…

Continue Reading

FridaySep 15, 2023 10:23 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Leveraging Technology, Innovative Services to Enhance US Safety

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, is leveraging technology to improve public safety across the U.S. utilizing Amazon.com Inc.’s (NASDAQ: AMZN) Amazon Web Services (“AWS”). The announcement reads, “In Huntington Park, California, Knightscope’s K5 Autonomous Security Robot (‘ASR’) helped reduce calls for service by 10% and crime reports by 46% during its first year of deployment. The city council subsequently voted unanimously to extend their contract and has recently awarded Knightscope a contract for its 5th year of service. Knightscope leveraged nearly a dozen AWS services to support this project.…

Continue Reading

ThursdaySep 14, 2023 2:22 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Releases Upcoming Destinations for 2023 Strikingly Different EV Experience

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is announcing new stops on its 2023 Strikingly Different EV U.S. tour. This month the EV experience will be in North Carolina as well as Washington, D.C., Philadelphia, New York City and Boston. This year’s Strikingly Different tour began in August, with its first stop in Austin, Texas; the innovative in-person tour is slated to go through November 2023 and includes destinations in the South and Midwest as well as on both the East and West Coasts. Announced tour stops in October include Detroit, Denver, Salt Lake City and Sonoma,…

Continue Reading

WednesdaySep 13, 2023 2:11 pm

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Unveils Grant Program to Ensure School Safety

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, announced the launch of its School Safety Grant Program. According to the announcement, Knightscope’s program makes the safety of schools, children and teachers a top priority and is designed to empower individuals and promote safer learning environments in K-12 schools. Knightscope understands that violence, harassment and threats against students, teachers and school staff have a significant negative impact on the ability for children to obtain a quality education in a safe environment. Creating a supportive school culture is the first line of defense,…

Continue Reading

TuesdaySep 12, 2023 12:35 pm

TinyGemsBreaks – GEMXX Corp. (GEMZ) Announces Plans to Expand Ammolite Production, On-Air Presence

GEMXX (OTC: GEMZ), a leader in the ammolite gems mine-to-market segment, today announced that demand for GEMXX Ammolite in jewelry designs by Kenneth Bradley is exponentially growing. According to the update, the presence of GEMXX Ammolite is expanding in the United States and around the world. Live, on-air events showcase uniquely beautiful GEMXX Ammolite gemstones in jewelry by Kenneth Bradley designs. In March of 2023, GEMXX signed an exclusive supply agreement with Canadian Ammolite Gems by Kenneth Bradley. To supply the growing demand, GEMXX plans to expand gemstone and jewelry production by 300% year over year, and its shopping channel…

Continue Reading

MondaySep 11, 2023 1:09 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Strategic Acquisition of Romeo Power Assets

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its purchase of battery pack production assets from Romeo Power for approximately $3.5 million. According to the announcement, the deal includes equipment, inventory and intellectual property for high volume EV battery pack and module production. The assets include production lines for EV pack assembly and precision R&D module and pack development with associated inventory allowing for production of modules and vehicle battery packs. In addition, the purchased assets include battery testing and validation equipment, computer numerical control (“CNC”) equipment for battery pack and module enclosure production. “Purchasing the…

Continue Reading

FridaySep 08, 2023 12:22 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) ‘Strategically Important’ Patent Grants Protection in One of World’s Leading Oral Nicotine Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently celebrated the receipt of U.S. patent #11,700,875, titled “Compositions and Methods For Sublingual Delivery of Nicotine.” The patent covers various forms and sources of nicotine, including nicotine benzoate, nicotine polacrilex, nicotine citrate, nicotine detartrate, and many others, for use in sublingual delivery formats like oral pouches. “The new U.S. patent is remarkable and ‘strategically important’ in many ways. First, it is the company’s 35th overall granted patent worldwide and the 13th granted in the United States. Second, a total of 30 claims were awarded within this patent,…

Continue Reading

FridaySep 08, 2023 11:25 am

TinyGemsBreaks – GEMXX Corp. (GEMZ) Eyes Promising Start to Expected ‘Highly Lucrative’ First Year of Gold Mining

GEMXX (OTC: GEMZ), a mine-to-market global jewelry producer, is ramping up its capacity for gold ore processing at one of its Canadian assets, enthusiastic over the better-than-expected amount of ore produced from stockpiled surface material. “GEMXX’s Snow Creek Mine property in British Columbia completed site preparation for gold processing last year and mobilized equipment in May to begin bringing the property into full production. GEMXX reported the first production of gold from the site on Aug. 15 as ore collected from a 4,500-cubic-yard sample during construction of the facility was ‘cleaned out.’ The operation yielded 38.73 ounces of gold, amounting…

Continue Reading

FridaySep 08, 2023 10:38 am

TinyGemsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K5 ASRs for New Client, 2nd-Year Contract Renewal

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced another new deployment and contract renewal for K5 ASRs. The announcement reads, “Knightscope’s commitment to making children safe extends beyond the classroom and into extracurricular and recreational activities. With over 3.5 billion followers worldwide, soccer is the number one sport on planet Earth, and Knightscope has begun protecting a new generation of players and fans in New York. A soccer academy and sports complex in Long Island now has a K5 ASR securing its entrance against trespassers and patrolling its parking…

Continue Reading

ThursdaySep 07, 2023 4:56 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 200-Patient Enrollment Milestone in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced enrollment of 200 of the expected 243 patients in the company’s ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent Glioblastoma Multiforme (“GBM”), an aggressive and incurable form of brain cancer. “As we have noted previously, patient volunteers and their treating clinicians are the backbone of our Berubicin development program. We are deeply sensitive to the fact that these brave patients are facing the battle of their lives and we…

Continue Reading

Contact us: (512) 354-7000